StockNews.com Begins Coverage on ClearSign Technologies (NASDAQ:CLIR)

Equities research analysts at StockNews.com initiated coverage on shares of ClearSign Technologies (NASDAQ:CLIRGet Free Report) in a research note issued on Saturday. The brokerage set a “sell” rating on the technology company’s stock.

ClearSign Technologies Trading Up 9.9 %

NASDAQ CLIR opened at $1.22 on Friday. The company has a 50-day moving average price of $1.01 and a two-hundred day moving average price of $0.87. ClearSign Technologies has a 52 week low of $0.62 and a 52 week high of $1.32. The stock has a market cap of $61.29 million, a price-to-earnings ratio of -11.09 and a beta of 1.14.

Institutional Trading of ClearSign Technologies

An institutional investor recently raised its position in ClearSign Technologies stock. Geode Capital Management LLC lifted its stake in shares of ClearSign Technologies Co. (NASDAQ:CLIRFree Report) by 35.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 521,229 shares of the technology company’s stock after purchasing an additional 136,639 shares during the quarter. Geode Capital Management LLC owned about 1.04% of ClearSign Technologies worth $443,000 at the end of the most recent reporting period. Institutional investors own 24.03% of the company’s stock.

About ClearSign Technologies

(Get Free Report)

ClearSign Technologies Corporation designs and develops products and technologies to enhance emission and operational performance, energy efficiency, emission reduction, safety, and overall cost-effectiveness of industrial and commercial systems in the United States, the People's Republic of China, and Hong Kong.

Featured Articles

Receive News & Ratings for ClearSign Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ClearSign Technologies and related companies with MarketBeat.com's FREE daily email newsletter.